Europe Respiratory Care Devices Market to Reach USD 12.97 Billion by 2033

Introduction

As per Renub Research study Europe Respiratory Care Devices Market is projected to grow from USD 6.8 billion in 2024 to USD 12.97 billion by 2033, registering a CAGR of 7.45% from 2025 to 2033. Increasing prevalence of respiratory diseases, a rising elderly population, urban pollution, and heightened post-COVID-19 health consciousness are key factors driving growth.

Government support, strong healthcare infrastructure, and rising demand for homecare respiratory devices further promote market expansion. Technological advancements—such as smart inhalers, portable oxygen concentrators, and AI-powered monitoring devices—enhance patient comfort and adherence, while expanding the overall market opportunities.

Market Overview

Respiratory care devices assist patients suffering from asthma, COPD, sleep apnea, and respiratory infections, offering solutions for diagnosis, monitoring, and therapy. Common devices include ventilators, nebulizers, oxygen concentrators, CPAP machines, inhalers, and spirometers.

👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Free Sample Report

Market growth is driven by:

Rising prevalence of respiratory diseases due to pollution, smoking, and urbanization.

Increasing homecare adoption, reducing dependence on hospital-based treatment.

Integration of digital health solutions and telemedicine, improving patient outcomes.

Technological innovation has resulted in devices that are portable, automated, and patient-friendly, addressing both chronic and acute respiratory disorders and improving quality of life.

Growth Drivers

1. Rising Prevalence of Respiratory Diseases

Europe faces increasing incidence of asthma, COPD, and obstructive sleep apnea. For example, Germany reports asthma prevalence of nearly 10% in children and 4–5% in adults. Rising demand for diagnostic, monitoring, and therapeutic devices is fueling market expansion.

2. Technological Advancements

Innovations like smart inhalers, AI-integrated ventilators, and cloud-based monitoring devices improve patient adherence and clinical outcomes. Collaborations, such as MAGNET GROUP leveraging KoKo LLC’s advanced spirometry software, highlight the integration of digital health into respiratory care.

3. Aging Population

Europe’s aging population is particularly vulnerable to respiratory disorders. 21.6% of the EU population is aged 65+, increasing demand for user-friendly, homecare-compatible respiratory devices.

Market Challenges

1. High Device Costs

Advanced respiratory devices—CPAP machines, ventilators, and portable oxygen concentrators—carry high initial and maintenance costs, limiting access in lower-income regions and among the elderly.

2. Regulatory Hurdles

EU Medical Device Regulation (MDR) introduces stringent requirements for clinical evaluation, labeling, and post-market surveillance. While these regulations ensure safety and quality, they increase compliance costs and approval times, affecting smaller manufacturers.

Regional Market Insights

Germany

Germany’s market benefits from an aging population and high prevalence of respiratory conditions. Innovations in smart inhalers, CPAP machines, and portable oxygen concentrators are prominent. Funding initiatives, such as Bavaria’s EUR 225,000 grant for wearable respiratory monitoring devices, support digital health adoption.

France

France faces a high asthma prevalence (13.5%) and a growing elderly population, driving demand for oxygen concentrators, nebulizers, and inhalers. Homecare adoption and technological innovation enhance patient outcomes.

United Kingdom

The UK market is driven by post-COVID health awareness and technological advancements in respiratory devices. Companies like Honeywell and Responsive Respiratory are introducing NIOSH-certified respirators and innovative sanitization devices, supporting both hospital and homecare environments.

👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report

Market Segmentation

By Application:

Chronic Obstructive Pulmonary Disease (COPD)

Obstructive Sleep Apnea

Asthma

Respiratory Distress Syndrome

Cystic Fibrosis

Others

By Device Type:

Therapeutic Devices

Monitoring Devices

Diagnostic Devices

Consumables & Accessories

By Product Type:

Respiratory Consumables

Nebulizers

Oxygen Concentrators

Polysomnography Devices

Pulse Oximeters

Mechanical Ventilators

Spirometers

Others

By End User:

Hospitals

Home Care

Ambulatory Care

By Country:

France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Russia, Poland, Greece, Norway, Romania, Portugal, Rest of Europe

Competitive Landscape

Key Players:

Medtronic Plc

Koninklijke Philips

General Electric Company

Masimo Corporation

ResMed Inc.

Becton, Dickinson and Company

Chart Industries Inc.

Getinge AB

Companies are focusing on technological innovation, homecare adoption, and patient-centric solutions, while navigating regulatory compliance and cost pressures.

Future Outlook

The Europe Respiratory Care Devices Market is expected to experience robust growth through 2033, driven by:

Increasing respiratory disease prevalence

Rising homecare demand

Technological innovations and AI integration

Growing aging population and post-pandemic health awareness

Challenges like high device costs and regulatory complexity will encourage innovation, partnerships, and adoption of cost-effective homecare solutions, positioning Europe as a key market for advanced respiratory care devices.

Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.